Literature DB >> 378651

Bromocriptine in the treatment of acromegaly.

D E Bateman, W M Tunbridge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 378651     DOI： 10.2165/00003495-197917050-00005

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  28 in total

1.  Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel.

Authors:  J Takahara; A Arimura; A V Schally
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

2.  Stimulation of human-growth-hormone secretion by L-dopa.

Authors:  A E Boyd; H E Lebovitz; J B Pfeiffer
Journal:  N Engl J Med       Date:  1970-12-24       Impact factor: 91.245

3.  Long-term treatment of acromegaly with bromocriptine.

Authors:  J A Wass; M O Thorner; D V Morris; L H Rees; A S Mason; A E Jones; G M Besser
Journal:  Br Med J       Date:  1977-04-02

4.  Radiological evidence for regression of prolactinoma after treatment with bromocriptine.

Authors:  L G Sobrinho; M C Nunes; M A Santos; J C Mauricio
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

5.  Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma.

Authors:  P Gorden; M A Lesniak; R Eastman; C M Hendricks; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1976-08       Impact factor: 5.958

6.  Bromocriptine treatment of acromegaly.

Authors:  M O Thorner; A Chait; M Aitken; G Benker; S R Bloom; C H Mortimer; P Sanders; A S Mason; G M Besser
Journal:  Br Med J       Date:  1975-02-08

7.  Bromocriptine treatment of acromegaly.

Authors:  J Cassar; K Mashiter; G F Joplin
Journal:  Metabolism       Date:  1977-05       Impact factor: 8.694

8.  Bromocriptine therapy in acromegaly.

Authors:  Y Sachdev; A Gomez-Pan; W M Tunbridge; A Duns; D R Weightman; R Hall; S K Goolamali
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

9.  Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months.

Authors:  G Schwinn; H Dirks; C McIntosh; J Köbberling
Journal:  Eur J Clin Invest       Date:  1977-04       Impact factor: 4.686

10.  Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.

Authors:  A Liuzzi; P G Chiodini; L Botalla; F Silvestrini; E E Müller
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958
View more
  1 in total

1.  The effect of food and metoclopramide on the pharmacokinetics and side effects of bromocriptine.

Authors:  Z Kopitar; B Vrhovac; L Povsic; F Plavsić; I Francetić; J Urbancic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.